Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Capital Leases: 2010-2018

Historic Capital Leases for Ironwood Pharmaceuticals (IRWD) over the last 6 years, with Dec 2018 value amounting to $158,000.

  • Ironwood Pharmaceuticals' Capital Leases was N/A to $158,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $158,000, marking a year-over-year change of. This contributed to the annual value of $158,000 for FY2018, which is N/A change from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Capital Leases of $158,000 as of Q4 2018, which was up 652.38% from $21,000 recorded in Q1 2017.
  • Over the past 5 years, Ironwood Pharmaceuticals' Capital Leases peaked at $3.2 million during Q2 2014, and registered a low of $21,000 during Q1 2017.
  • Moreover, its 3-year median value for Capital Leases was $149,500 (2016), whereas its average is $142,167.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Capital Leases surged by 1,494.95% in 2014 and then crashed by 91.70% in 2017.
  • Over the past 5 years, Ironwood Pharmaceuticals' Capital Leases (Quarterly) stood at $2.6 million in 2014, then crashed by 88.10% to $306,000 in 2015, then crashed by 73.20% to $82,000 in 2016, then slumped by 91.70% to $21,000 in 2017, then reached $158,000 in 2018.
  • Its last three reported values are $158,000 in Q4 2018, $21,000 for Q1 2017, and $82,000 during Q4 2016.